Current status of endoscopic resection for small rectal neuroendocrine tumors

Jian-Ning Liu1, Hui Chen2, Nian Fang1,3

  • 1Department of Gastroenterology, The Third Affiliated Hospital, Jiangxi Medical College, School of Queen Mary, Nanchang University, Nanchang 330009, Jiangxi Province, China.

Insights

Rectal neuroendocrine tumors (rNETs) are increasingly detected during screening. Modified endoscopic submucosal resection with submucosal stretching offers a favorable option for complete resection of small rNETs.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Endoscopic Therapeutics

Background:

  • Rectal neuroendocrine tumors (rNETs) are indolent malignancies with a 10-fold increased incidence over 30 years.
  • Most detected rNETs are small (<10 mm) and found during colonoscopy screening.
  • Current guidelines suggest endoscopic resection, but optimal methods are debated.

Purpose of the Study:

  • To summarize evidence on endoscopic resection techniques for rNETs.
  • To evaluate the efficacy and safety of different endoscopic modalities.
  • To propose a treatment algorithm for clinical decision-making.

Main Methods:

  • Review of evidence on modified endoscopic submucosal resection (mEMR) with and without submucosal stretching.
  • Evaluation of endoscopic submucosal dissection (ESD) and endoscopic full-thickness resection (EFTR).
  • Analysis of risk factors for lymph node and distant metastases.

Main Results:

  • Achieving adequate resection depth is critical due to submucosal invasion in rNETs.
  • mEMR with submucosal stretching demonstrated a high rate of histological complete resection.
  • This technique also showed favorable safety and convenience profiles.

Conclusions:

  • Modified endoscopic submucosal resection with submucosal stretching is a promising treatment for rNETs.
  • The technique ensures histological complete resection with good safety.
  • A proposed algorithm aids in clinical decision-making for rNET management.